Featured Research

from universities, journals, and other organizations

E-cigarettes: Not a healthy alternative to smoking; Allergists warn e-smokers of unknown risks

Date:
May 27, 2014
Source:
American College of Allergy, Asthma, and Immunology
Summary:
A new study examines the risks of e-cigarettes, and concludes that they are not a healthy alternative to smoking. A new article examines the idea that one of the initial "health benefits" proposed by e-cigarettes makers was that it would help those who smoke cigarettes cut back. The authors say that theory hasn't been proven, and there's no evidence to support the claims.

Caveat emptor -- or "buyer beware" holds true when it comes to the unknown health effects of e-cigarettes. An article in the June issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), examines risks, including the ongoing dependence on nicotine and the dual use of e-cigarettes and regular cigarettes.

The article examines the idea that one of the initial "health benefits" proposed by e-cigarettes makers was that it would help those who smoke cigarettes cut back. The authors say that theory hasn't been proven, and there's no evidence to support the claims.

"Despite the apparent optimism surrounding e-cigarettes and their purported therapeutic role in smoking cessation, there just simply is not enough evidence to suggest that consumers should use e-cigarettes for this purpose." said allergist Andrew Nickels, MD, lead author, ACAAI member, Mayo Clinic Division of Allergy and Immunology.

Another cause for concern is that when people use e-cigarettes in public and still smoke regular cigarettes at home, they continue to expose children and asthma sufferers in the household to dangerous second hand smoke.

"Dual use of both e-cigarettes and regular cigarettes carries the risk of secondhand smoke exposure, causing worsening respiratory effects on children and asthma sufferers. It also promotes ongoing nicotine dependence," said Chitra Dinakar, MD, co-author, ACAAI fellow and Professor of Pediatrics, Children's Mercy Hospitals.

Because e-cigarettes are fairly new, there could be other long-term health complications that have yet to be discovered. Results of long-term exposure to such substances are unknown. Due to the lack of production oversight, most consumers don't know what's in the e-cigarettes they buy. The US Food and Drug Administration admits that the safety and efficacy of e-cigarettes hasn't been fully studied, and consumers have no way of knowing if e-cigarettes are safe for their intended use.

Organizations like ACAAI are advocating for enhanced scrutiny and regulation by the FDA. The ACAAI's position statement on e-cigarettes recognizes that nicotine delivered by any mechanism represents a drug exposure, and that vaporization instruments are a drug delivery system, both of which are within the Federal Drug Agency's scope of regulation.

Inhaling irritants such as smoke and vapors has an impact on the lungs, whether it is mild or severe. And irritants can cause asthma attacks in some individuals. These attacks are responsible for some of the 4,000 asthma-related deaths per year.


Story Source:

The above story is based on materials provided by American College of Allergy, Asthma, and Immunology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Andrew S. Nickels, Avni Y. Joshi, Chitra Dinakar. Electronic cigarettes: navigating the vapor. Annals of Allergy, Asthma & Immunology, May 2014

Cite This Page:

American College of Allergy, Asthma, and Immunology. "E-cigarettes: Not a healthy alternative to smoking; Allergists warn e-smokers of unknown risks." ScienceDaily. ScienceDaily, 27 May 2014. <www.sciencedaily.com/releases/2014/05/140527100644.htm>.
American College of Allergy, Asthma, and Immunology. (2014, May 27). E-cigarettes: Not a healthy alternative to smoking; Allergists warn e-smokers of unknown risks. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/05/140527100644.htm
American College of Allergy, Asthma, and Immunology. "E-cigarettes: Not a healthy alternative to smoking; Allergists warn e-smokers of unknown risks." ScienceDaily. www.sciencedaily.com/releases/2014/05/140527100644.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins